A team from the University of Pittsburgh's McGowan Institute for Regenerative Medicine has shown the potential for clinical use of the drag-reducing polymer (DRP) poly(N-vinylformamide), or PNVF. The high molecular weight PNVF is shown to reduce resistance to turbulent flow in a pipe and to enhance blood flow in animal models and it also withstands mechanical stresses much more readily than poly(ethylene oxide).